Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 2.87 Delayed Data As of Jul 21 |  +0.07 / +2.50%Today’s Change | 0.78 Today|||52-Week Range 5.59 | -20.28% Year-to-Date |
| Indexes Inch Lower After European Central Bank's Meeting Jul 21 / GuruFocus News - Paid Partner Content |
| Previous close | 2.80 |
| Today’s open | 3.20 |
| Day’s range | 2.65 - 3.22 |
| Volume | 17,690,993 |
| Average volume (3 months) | 1,763,452 |
| Market cap | $41.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +86.71% |
| Earnings growth (this year) | +43.42% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +67.16% |
| P/E ratio | -- |
| Price/Sales | 42.25 |
| Price/Book | 5.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| HTGMHTG Molecular Diagno... | +0.05 | +2.16% |
| PRTOProteon Therapeutics... | -0.02 | -1.82% |
| FSIFlexible Solutions I... | +0.06 | +3.28% |
| RKDAArcadia Biosciences ... | 0.00 | 0.00% |
| Next reporting date | August 15, 2017 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $911.0K |
| Annual profit (last year) | -$25.0M |
| Net profit margin | -2,739.74% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer Michael Ward |
Chief Accounting Officer & Vice President-Finance Geneviève Lemaire |
Corporate headquarters Montréal, Quã©bec |
